MANTRA / USDC

Intellia Therapeutics (NASDAQ:NTLA) Receives Sell Rating from The Goldman Sachs Group

01 Mar 2025 08:32:14 By Buzz FX

Telsey Advisory Group Reiterates Outperform Rating for Vital Farms (NASDAQ:VITL)

01 Mar 2025 08:32:14 By Buzz FX

Deutsche Bank Aktiengesellschaft Boosts Primo Brands (NYSE:PRMB) Price Target to $40.00

01 Mar 2025 08:32:14 By Buzz FX

Pacira BioSciences (NASDAQ:PCRX) Given New $32.00 Price Target at Needham & Company LLC

01 Mar 2025 08:32:14 By Buzz FX

Stifel Nicolaus Downgrades Vertex (NASDAQ:VERX) to Hold

01 Mar 2025 08:32:14 By Buzz FX

Telsey Advisory Group Reiterates Outperform Rating for Traeger (NYSE:COOK)

01 Mar 2025 08:32:14 By Buzz FX

Stagwell (NASDAQ:STGW) Price Target Raised to $10.00

01 Mar 2025 08:32:14 By Buzz FX

Monster Beverage (NASDAQ:MNST) Price Target Raised to $61.00

01 Mar 2025 08:32:14 By Buzz FX

HC Wainwright Reaffirms Buy Rating for Cytokinetics (NASDAQ:CYTK)

01 Mar 2025 08:32:14 By Buzz FX

Needham & Company LLC Boosts Duolingo (NASDAQ:DUOL) Price Target to $400.00

01 Mar 2025 08:32:14 By Buzz FX

argenx (NASDAQ:ARGX) Given New $720.00 Price Target at HC Wainwright

01 Mar 2025 08:32:14 By Buzz FX

HC Wainwright Reiterates "Buy" Rating for Opthea (NASDAQ:OPT)

01 Mar 2025 08:32:14 By Buzz FX

Acadia Healthcare (NASDAQ:ACHC) Price Target Lowered to $44.50 at Bank of America

01 Mar 2025 08:32:14 By Buzz FX

HC Wainwright Lowers Dyne Therapeutics (NASDAQ:DYN) Price Target to $46.00

01 Mar 2025 08:32:14 By Buzz FX

HC Wainwright Forecasts Strong Price Appreciation for Cardiff Oncology (NASDAQ:CRDF) Stock

01 Mar 2025 08:32:14 By Buzz FX

ADTRAN (NASDAQ:ADTN) Receives "Buy" Rating from Rosenblatt Securities

01 Mar 2025 08:32:14 By Buzz FX

Merus (NASDAQ:MRUS) Given New $83.00 Price Target at Needham & Company LLC

01 Mar 2025 08:32:14 By Buzz FX

Okta (NASDAQ:OKTA) Receives "Buy" Rating from Westpark Capital

01 Mar 2025 08:32:14 By Buzz FX

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $72.00 at HC Wainwright

01 Mar 2025 08:32:14 By Buzz FX

Duolingo (NASDAQ:DUOL) Price Target Raised to $390.00

01 Mar 2025 08:32:14 By Buzz FX